Microbial transformation of N-methylcolchiceinamide

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Colchicine analogs are used as antineoplastic agents.
• Understanding microbial metabolism of such compounds is crucial for drug development and biotransformation studies.

Purpose of the Study:

• To screen microorganisms for their ability to metabolize N-methylcolchiceinamide.
• To identify and characterize the metabolites produced by effective microbial strains.

Main Methods:

• Seventy-seven microorganisms were screened for N-methylcolchiceinamide metabolism.
• Preparative-scale biotransformation using Streptomyces griseus NRRL B-599.
• Chemical, spectroscopic, and chromatographic analyses for metabolite identification.

Main Results:

• Five streptomycetes showed significant metabolism.
• Streptomyces griseus NRRL B-599 completely converted the substrate into three metabolites.
• Colchiceinamide was the major metabolite (65%) produced via N-dealkylation.
• Two O-demethylated phenolic metabolites were identified.

Conclusions:

• Streptomyces griseus NRRL B-599 is capable of significant N-methylcolchiceinamide biotransformation.
• The study identified key metabolites, including colchiceinamide and demethylated derivatives.
• This microbial metabolism pathway offers potential for novel drug development and production.